NanoGroup raised PLN 4.7 million from the issue of L and M1 shares
As a result of the subscription of L-series shares and M1-series shares carried out in May, NanoGroup concluded share subscription agreements for a total issue
As a result of the subscription of L-series shares and M1-series shares carried out in May, NanoGroup concluded share subscription agreements for a total issue
More than PLN 9 million – this is the total value of the financing that, under the agreement concluded between eCapital sp. z o.o. and
Michal Lach has bet millions on a WSE biotech group that recently came close to insolvency. NanoGroup is also supported by other investors. The entire
NanoGroup S.A. has entered into an agreement with eCapital sp. z o.o., based in Warsaw (Investor), an investment agreement. The Investment Agreement states that: a.
The Management Board of NanoGroup S.A. has received offers from investors interested in acquiring series L shares issued (on the basis of the resolution of
In addition to the kidneys and liver, the innovative NanOx system also works well in heart perfusion, as proven by a recent study conducted in
The conducted pig liver perfusion is another step taken by the company to introduce an innovative organ perfusion system to the Polish market. NanoGroup’s first
Today on Fakty TVN, Prof. Dr. Katherine H. K., a professor of transplantation, spoke about our research, the record time for keeping a kidney out
Prof. NanoGroup S.A. talks about the future of transplantation, the possibilities that the technology being developed by NanoGroup S.A. opens up for the field, and
“The problem of transplantation – at least in the case of the kidney – is that there is still no definitively established one or more
Nanotechnology expert. Professor at the Faculty of Chemical and Processing Engineering, Warsaw University of Technology, head of the Biotechnology and Bioprocessing Division. Author of two technologies that are already in production stage, 12 granted patents and over 50 publications. Founder of BioMedLab research group, consultant in numerous companies (AstraZeneca, Procter and Gamble, Reckit, Adamed, Balton, Galmed). Work on various aspects of Biomedical Engineering, mostly on biomedical nanotechnology, active coatings for medical implants, nanoparticles for cancer treatment, biodegradable and nonbiodegradable implants, bone and vascular prosthesis. He gives rare, but already brilliant example of how brave ideas become socially and financially valuable.
Clinical pharmacology specialist, former advisor to the Minister of Health on drug policy. He negotiated Poland’s accession to the EU in the field of pharmacy, responsible for the implementation of EU directives in the field of pharmacy into the Polish legal system. Co-founder of the Office for Registration of Medicinal Products, Medical Devices and Biocidal Products. Owner of a consulting company cooperating with international pharmaceutical companies in the field of introducing new technologies to the Polish market.
Associated with the health market since 2004. As Managing Director, he restructured and developed the most dynamically operating Medical Center in the Podkarpacie region, creating and setting new standards of customer service quality on the market. Co-creator of the first solution in Poland for online registration of medical appointments. Co-founder of the first and only Infertility Treatment Clinic (MEDICOR) in Podkarpacie, which he headed as the President until 2009. He was responsible for the development of health insurance in the PZU Group. As Vice President of PZU Pomoc S.A. created the largest medical TPA in Poland to handle health insurance. Co-founder of the first drug insurance in Poland. Since 2015, he has been active in the field of Wealth Management and advises on management and finance. A graduate of International Economic and Political Relations as well as Management and Marketing at the Warsaw School of Economics.
Associated with the health market since 2004. As Managing Director, he restructured and developed the most dynamically operating Medical Center in the Podkarpacie region, creating and setting new standards of customer service quality on the market. Co-creator of the first solution in Poland for online registration of medical appointments. Co-founder of the first and only Infertility Treatment Clinic (MEDICOR) in Podkarpacie, which he headed as the President until 2009. He was responsible for the development of health insurance in the PZU Group. As Vice President of PZU Pomoc S.A. created the largest medical TPA in Poland to handle health insurance. Co-founder of the first drug insurance in Poland. Since 2015, he has been active in the field of Wealth Management and advises on management and finance. A graduate of International Economic and Political Relations as well as Management and Marketing at the Warsaw School of Economics.